These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1948870)

  • 1. [Cooperation between physicians and pharmaceutical consultants. A questionnaire study].
    Husby T
    Tidsskr Nor Laegeforen; 1991 Sep; 111(22):2758-60. PubMed ID: 1948870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Physicians and pharmaceutical consultants].
    Nessa J
    Tidsskr Nor Laegeforen; 1991 Sep; 111(22):2722-3. PubMed ID: 1948861
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmaceutical consultants and drug information].
    Kormeset PO
    Tidsskr Nor Laegeforen; 2008 Aug; 128(15):1684-5. PubMed ID: 18704147
    [No Abstract]   [Full Text] [Related]  

  • 4. Attitudes of general practitioners in New Zealand to pharmaceutical representatives.
    Thomson AN; Craig BJ; Barham PM
    Br J Gen Pract; 1994 May; 44(382):220-3. PubMed ID: 8204336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Physicians' contact with the drug industry. An interview among general practitioners].
    Husby T; Tertnes AD; Skuseth G
    Tidsskr Nor Laegeforen; 1990 Apr; 110(10):1237-9. PubMed ID: 2333651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Attitudes of general practitioners to pharmaceutical sales representatives in Sousse].
    Ben Abdelaziz A; Harrabi I; Rahmani S; Ghedira A; Gaha K; Ghannem H
    East Mediterr Health J; 2003; 9(5-6):1075-83. PubMed ID: 16450540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of services provided by pharmaceutical companies: perceptions of physicians and pharmaceutical sales representatives.
    Gaedeke RM; Tootelian DH; Sanders EE
    Health Mark Q; 1999; 17(1):23-31. PubMed ID: 11066720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How do general practitioners rate their relationship with gastroenterologists?
    Cardin F; Franco-Novelletto B; Fassina R; Sturniolo G
    Dig Liver Dis; 2004 May; 36(5):315-21. PubMed ID: 15191199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescribing new drugs: qualitative study of influences on consultants and general practitioners.
    Jones MI; Greenfield SM; Bradley CP
    BMJ; 2001 Aug; 323(7309):378-81. PubMed ID: 11509431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding why GPs see pharmaceutical representatives: a qualitative interview study.
    Prosser H; Walley T
    Br J Gen Pract; 2003 Apr; 53(489):305-11. PubMed ID: 12879831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experiences of physicians and nurses with the occupational environment in health centers in Oslo--how do they have it and how do they take it].
    Buxrud EG
    Tidsskr Nor Laegeforen; 1991 Jun; 111(15):1869-73. PubMed ID: 1853324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing at the hospital-general practice interface. II: Impact of hospital outpatient dispensing policies in England on general practitioners and hospital consultants.
    Sibbald B; Wilkie P; Raftery J; Anderson S; Freeling P
    BMJ; 1992 Jan; 304(6818):31-4. PubMed ID: 1734993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doctors' Interactions with Pharmaceutical Sales Representatives: Modelling Doctors Prescription Behaviour.
    Faisal A; Ahmad MS; Thurasamy R; Ahmed R
    Community Ment Health J; 2020 Apr; 56(3):456-463. PubMed ID: 31728716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicines information provided by pharmaceutical representatives: a comparative study in Australia and Malaysia.
    Othman N; Vitry AI; Roughead EE; Ismail SB; Omar K
    BMC Public Health; 2010 Nov; 10():743. PubMed ID: 21118551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General practitioner and hospital specialist attitudes to functional gastrointestinal disorders.
    Gladman LM; Gorard DA
    Aliment Pharmacol Ther; 2003 Mar; 17(5):651-4. PubMed ID: 12641513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes of general practitioners to their interactions with pharmaceutical companies: a qualitative study.
    Quinn RJ; O'Neill C
    Ir Med J; 2002; 95(7):199-202. PubMed ID: 12227525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of interactions between pharmaceutical representatives and ophthalmology trainees.
    Wang Y; Adelman RA
    Am J Ophthalmol; 2009 Oct; 148(4):619-622.e3. PubMed ID: 19570520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encounters with pharmaceutical sales representatives among practicing internists.
    Ferguson RP; Rhim E; Belizaire W; Egede L; Carter K; Lansdale T
    Am J Med; 1999 Aug; 107(2):149-52. PubMed ID: 10460046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors.
    Edwards D; Ballantyne A
    Intern Med J; 2009 Mar; 39(3):191-6. PubMed ID: 19383067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mental health nursing students' relationships with the pharmaceutical industry.
    Ashmore R; Carver N; Banks D
    Nurse Educ Today; 2007 Aug; 27(6):551-60. PubMed ID: 17113686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.